| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -110.74M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XENE returned +56.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +35.6% |
| 1 year | +56.5% |
| 5 years | +244.3% |
| 10 years | +661.8% |
| All-time high | $62.67 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in XENE would be worth today ›No. Xenon Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
Xenon Pharmaceuticals Inc. stock trades on NASDAQ under the ticker symbol XENE.
Xenon Pharmaceuticals Inc. is part of the Healthcare sector.
Xenon Pharmaceuticals Inc. has a market cap of 5.88B USD, based on the latest quote.
Xenon Pharmaceuticals Inc. is expected to report earnings around Nov 2, 2026. That date is an estimate and has not been confirmed by the company.
